We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 10

AstraZeneca v Novopharm, motion to adduce video-recordings of cross-examinations of expert witnesses in a PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

AstraZeneca brought a motion seeking an order that video-recordings of cross-examinations of expert witnesses in the proceedings be filed as part of the Application Record and available at the hearing

Novopharm v. Eli Lilly, appeals of decisions of the Case Management Prothonotary

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Eli Lilly appealed two interlocutory decisions made by the Case Management Prothonotary

Apotex v Sanofi, case management directions on the late disclosure of documents or information

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Prior to a case management conference within a streamlined case, the Prothonotary ordered the parties to make submissions at the conference on the question of whether a date should be set after which the parties required either consent of the other party or leave of the Court to serve a supplementary affidavit of documents or a corrected or completed information in answer to a discovery question

Pfizer v. Apotex, PMNOC Regulations decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Apotex alleged in its NOA that Pfizer's patent was invalid for double patenting, anticipation, obviousness, lack of utility and over-breadth

Sanofi v ratiopharm, PMNOC Regulations decision irbesartan, March 5, 2010

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Sanofi sought an order prohibiting the granting of a NOC to ratiopharm

AstraZeneca v. Novopharm, appeal of decision to strike Statement of Claim

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes to strike AstraZeneca's Statement of Claim

Celgene Corporation v Canada (AG) - Supreme Court of Canada grants leave to appeal

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

The Supreme Court of Canada has granted Celgene Corporation's application for leave to appeal the decision of a majority of the Federal Court of Appeal regarding the jurisdiction of the Patented Medicine Prices Review Board

Merck v. Pharmascience, PMNOC Regulations decision

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

The Court, in a lengthy decision, dismissed an application for prohibition in respect of the drug finasteride, wherein allegations of invalidity had been raised, including grounds of double-patenting, novelty and obviousness

Astrazeneca v. Apotex, interlocutory motion to strike affidavit in PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

This was an appeal to the Federal Court of Appeal (FCA) of the decision of Justice Hughes refusing to strike an affidavit from the record

Pfizer v. Novopharm, interlocutory motion in PMNOC Regulations case

  • Gowling Lafleur Henderson LLP
  • -
  • Canada
  • -
  • May 21 2010

Novopharm served a NOA on Pfizer which it had designated confidential